PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival (NCT06896162)
Organization linked by public source evidence.
No public external ID is attached.
No reviewed person affiliation is attached.
No reviewed output is linked through affiliated people.
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival (NCT06896162)
No dated relationship evidence is attached.